Innovation Spirits
We have independently developed 10 minimally invasive interventional treatment solutions targeting tricuspid valve diseases, mitral valve diseases, aortic valve diseases, and heart failure. All products are based on our original innovation and possess global patents and independent intellectual property rights.

AnchorValve, our proprietary TMVR system, is designed to treat patients with severe mitral regurgitation. It works by replacing the function of a patient’s dysfunctional native mitral valve without the need for conventional open-heart surgery. AnchorValve consists of a prosthetic mitral valve, a delivery catheter system, and a loading system. Our AnchorValve uses a special anchoring design, and such design helps the fixation while preventing displacement. In addition, AnchorValve is also equipped with retrievable and steerable functions, which are expected to improve the valve positioning accuracy and stability during deployment.